Meg Tirrell

Reporter

Geron Plummets as FDA Halts Development of Blood Medicine

March 12, 2014

March 12, 2014

Geron Plummets as FDA Halts Development of Blood Medicine

March 7, 2014

March 7, 2014

Sanofi-Regeneron Must Assess Risk in New Cholesterol Drug

March 6, 2014

March 6, 2014

Sangamo Surges to 13-Year High on HIV Therapy Results

February 27, 2014

February 27, 2014

Illumina DNA Screen for Down Syndrome Found More Accurate

February 25, 2014

February 25, 2014

InterMune Soars on IPF Study That May Support Approval

February 21, 2014

February 21, 2014

Ariad Adds Activist Investor Alex Denner of Sarissa to Board

February 21, 2014

February 21, 2014

Incyte May Be Undervalued Even After Rise, New CEO Says

February 21, 2014

February 21, 2014

FDA Issues First Order to Stop Sale of Tobacco Products

February 20, 2014

February 20, 2014

JPMorgan Dad Starts Biotech in Muscular Dystrophy Quest

February 15, 2014

February 15, 2014

Biogen Names Papadopoulos as Its Chairman, Replacing Young

February 15, 2014

February 15, 2014

Biogen Said to Name Papadopoulos as New Chairman

February 12, 2014

February 12, 2014

Gilead’s Milligan Says Hepatitis C Drug Attracts Payers

February 5, 2014

February 5, 2014

Gilead Sinks on Lack of Forecast for Hepatitis C Drug

January 31, 2014

January 31, 2014

Amgen Readies Cholesterol Drug After Results From Trial

January 31, 2014

January 31, 2014

InterMune Sinks on Competition From Boehringer Lung Drug

January 30, 2014

January 30, 2014

Alexion Jumps as Lower-Than-Projected Tax Rate Boosts Profit

January 29, 2014

January 29, 2014

Biogen Profit Rises on Sales of Multiple Sclerosis Drugs

January 28, 2014

January 28, 2014

Amgen Fourth-Quarter Earnings Rise on Higher Drug Sales

January 24, 2014

January 24, 2014

Ariad Gains as Investors Bet on Takeover Interest

January 23, 2014

January 23, 2014

Baxter’s Fourth-Quarter Profit Beats Analysts’ Estimates